Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

April 18, 2006 16:53 ET | Source: Amazon Biotech, Inc.

Amazon Biotech, Inc. Announces Submitting of a Protocol to Test AMZ0026 as an HIV Drug to Delay Onset of AIDS With the FDA

NEW YORK, April 18, 2006 (PRIMEZONE) -- Amazon Biotech, Inc. (OTCBB:AMZB) today announced that it has filed a protocol to test AMZ0026 as an HIV drug to delay onset of full-blown AIDS with the Food...
April 04, 2006 08:24 ET | Source: Amazon Biotech, Inc.

Amazon Biotech Announces Development of a Redesigned HIV Protocol to Test AMZ0026 as an Add-On to Conventional HAART Therapy in HIV-1 Seropositive Pre-AIDS Subjects

NEW YORK, April 4, 2006 (PRIMEZONE) -- Amazon Biotech, Inc. (OTCBB:AMZB) today announced that it is redesigning its protocol for phase I/II trials to test AMZ0026 as an antiviral and immunomodulatory...
March 28, 2006 17:53 ET | Source: Amazon Biotech, Inc.

Amazon Biotech Announces Preparation of a Protocol to Test AMZ0026 as an HIV Drug to Delay Onset of Full-Blown AIDS

NEW YORK, March 28, 2006 (PRIMEZONE) -- Amazon Biotech, Inc. (OTCBB:AMZB) today announced that it is designing a protocol to test AMZ0026 as an HIV drug to delay onset of full-blown AIDS. The study is...
August 02, 2005 08:30 ET | Source: Amazon Biotech, Inc.

Amazon Biotech, Inc. Announces the Rights to Acquire EZ Orthopedics Inc.

NEW YORK, Aug. 2, 2005 (PRIMEZONE) -- Amazon Biotech, Inc. (OTCBB:AMZB) today announced that it has acquired the rights to purchase a controlling interest in EZ Orthopedics, a medical orthopedics...
March 14, 2005 08:30 ET | Source: Amazon Biotech, Inc.

Amazon Biotech Announces It Has Raised $600,000 to Advance Product Development and Seeks Up to $6 Million in Additional Capital

NEW YORK, March 14, 2005 (PRIMEZONE) -- Amazon Biotech, Inc. (OTCBB:AMZB), a developer and producer of AMZ 0026, a potential immunomodulator drug developed for use in the treatment of the HIV virus,...
March 08, 2005 14:55 ET | Source: Amazon Biotech, Inc.

Amazon Biotech, Inc. Announces the Appointment of Dr. Kathleen K. Casey, M.D., F.A.C.P., F.I.D.S.A. to its Scientific Advisory Board to Assist in the Phase I/II Study on AMZB Drug for AIDS AMZ0026

NEW YORK, March 8, 2005 (PRIMEZONE) -- Amazon Biotech, Inc. (OTCBB:AMZB) today announced the appointment of Kathleen K. Casey, M.D., F.A.C.P., F.I.D.S.A. to its Scientific Advisory Board. Dr. Casey...
January 19, 2005 09:54 ET | Source: Amazon Biotech, Inc.

Amazon Biotech, Inc. Announces the Appointment of Dr. Anthony J. Mangia, M.D., F.A.C.P to its Scientific Advisory Board to Assist in the Phase I/II on AMZB Drug for AIDS AMZ0026

NEW YORK, Jan. 19, 2005 (PRIMEZONE) -- Amazon Biotech, Inc. (OTCBB:AMZB) today announced the appointment of Anthony J. Mangia, M.D., F.A.C.P, to its Scientific Advisory Board. Dr. Mangia has over...
August 25, 2004 08:46 ET | Source: Amazon Biotech, Inc.

Amazon Biotech, Inc. Announces the Appointment of Dr. Arthur Englard to Its Scientific Advisory Board

NEW YORK, Aug. 25, 2004 (PRIMEZONE) -- Amazon Biotech, Inc. (OTCBB:AMZB) today announced the appointment of Arthur Englard M.D., Ph.D., to its Scientific Advisory Board. Dr. Englard is an Assistant...
July 07, 2004 08:41 ET | Source: Amazon Biotech, Inc.

Amazon Biotech Inc. Retains Strategic Growth as Investor Relations Advisor

NEW YORK, July 7, 2004 (PRIMEZONE) -- Amazon Biotech Inc. (OTCBB:AMZB), a New York-based pharmaceutical company engaged in the development of novel all-natural drugs, announced it has retained...
April 15, 2004 09:16 ET | Source: Amazon Biotech, Inc.

Amazon Biotech Inc. Announces the Appointment of Dr. Angelo Chinicci, as Company Chief Executive Officer

NEW YORK, April 15, 2004 (PRIMEZONE) -- Amazon Biotech Inc. (OTCBB:AMZB) today announced the appointment of Dr. Angelo A. Chinnici as Company Chief Officer. Dr. Chinicci has been in clinical practice...